Pharming Group N.V annual gross margin
2019
2020
2021
2022
2023
2024
2025
Pharming Group N.V Gross Margin Growth & History (PHAR)
Pharming Group N.V's gross margin was 87.90% for fiscal 2025.
View full Pharming Group N.V company overviewPharming Group N.V annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 87.90% | −0.19 pp |
| 2024 | 2024-12-31 | 88.09% | −1.63 pp |
| 2023 | 2023-12-31 | 89.72% | −1.74 pp |
| 2022 | 2022-12-31 | 91.46% | +2.09 pp |
| 2021 | 2021-12-31 | 89.37% | +0.46 pp |
| 2020 | 2020-12-31 | 88.91% | +1.54 pp |
| 2019 | 2019-12-31 | 87.37% | — |
Pharming Group N.V quarterly gross margin
No reported data
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|
Pharming Group N.V gross margin trends
Over the last five reported fiscal years, Pharming Group N.V's gross margin decreased from 88.91% to 87.90%, a change of −1.00 percentage points.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pharming Group N.V filings at SEC.gov ↗